Overview
A Pneumonia Vaccine Research Study for Ages 50+
A new clinical research study is currently enrolling participants to evaluate an investigational pneumococcal (pneumonia) vaccine. Unlike most studies that look for unvaccinated individuals, this research specifically needs volunteers who have already received a pneumonia vaccine in the past. Your vaccination history makes you a valuable candidate to help researchers understand potential future options for pneumonia protection.
About this Study
Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Subjects 50 Years of Age and Older with Prior Pneumococcal Vaccination
A clinical research study to evaluate an investigational vaccine designed to possibly protect against pneumococcal disease and pneumonia.
Who Can Join
- 50 years or older
- Have had a pneumonia vaccine in the past year
- Have never received a research (experimental) pneumonia vaccine
- Are in generally good health and have not had pneumococcal disease
- Have not had a live vaccine in the past 30 days
- Do not have HIV, Hepatitis B or C, cancer in the last 5 years, or a weakened immune system
- Not taking strong steroids or medicines that weaken the immune system (such as high-dose prednisone, chemotherapy, or transplant medications)
- Have not received a blood transfusion in the past 60 days
Not sure if you qualify? That’s okay.
A member of our recruitment team will review your medical history and medications with you to see if this study may be right for you.
What to Expect
Study Duration:
Up to 7 months
Study Visits:
Up to 2-3 site visits and 3 telephone calls
Compensation:
Participants may receive compensation up to $840